Drugs / budesonide/formoterol
last change Jan 2005 re-read 2 minutes ago

budesonide/formoterol

Developed for
asthma
Investigated by
AstraZeneca

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00651768 Aug 2003 → Jan 2005 asthma AstraZeneca Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as budesonide/formoterol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00651768
Route Inhaled “Symbicort pMDI + budesonide HFA pMDI” NCT00651768